Showing results (1951-1960 of 1,995) with videos related to

Sort By:
Pageof 200
Military Medical Research|September 30, 2025
Xenopax for the treatment of steroid-refractory acute graft-versus-host disease: the RELAX studyLe-Qing Cao, Wen-Xuan Huo, Er-Lie Jiang, et al.
American Journal of Cancer Research|September 15, 2021
Body mass index and type 2 diabetes and breast cancer survival: a Mendelian randomization studyYi-Shian Liu, Pei-Ei Wu, Wen-Cheng Chou, et al.
Hepatology International|February 24, 2026
Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablationChing-Wei Chang, Ming-Shun Wu, Wei-Yu Kao, et al.
Neuron|April 20, 2022
Glutamatergic synapses from the insular cortex to the basolateral amygdala encode observational painMing-Ming Zhang, An-Qi Geng, Kun Chen, et al.
Oncogene|May 1, 2018
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathwayJer-Wei Chang, Wen-Hung Kuo, Chiao-Mei Lin, et al.
Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.
British Medical Bulletin|April 4, 2025
All-inside arthroscopic procedures for chronic lateral ankle instability: evidence-based clinical practice guidelinesShi-Ming Feng, Nicola Maffulli, C Niek van Dijk, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomesTakashi Sakamoto, Julie Leca, Xin Zhang, et al.
Endocrine-Related Cancer|September 1, 2025
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancerTakayuki Ueno, Louis W C Chow, Wonshik Han, et al.
Nature Communications|May 14, 2021
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationHeng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, et al.
Pageof 200